18 June 2013
Keywords: western, biotechs, threatened, generic, east, new, study
Article | 08 May 2006
Following the first full market approval of a "biosimilar" within the last few weeks (that of Sandoz' Omnitrope, a generic ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 May 2006
1 May 2006
© 2013 thepharmaletter.com